(105 ILCS 5/10-20.36)
Sec. 10-20.36. Psychotropic or psychostimulant medication;
disciplinary
action.
(a) In this Section:
"Psychostimulant medication" means medication that produces increased
levels of mental and physical energy and alertness and an elevated mood
by stimulating the central nervous system.
"Psychotropic medication" means psychotropic medication as
defined in Section 1-121.1 of the Mental Health and Developmental
Disabilities Code.
(b) Each school
board
must adopt and implement a policy that prohibits any disciplinary action
that is based totally or in part on the refusal of a student's parent or
guardian to administer or consent to the administration of
psychotropic or psychostimulant medication to the student.
The policy must require that, at least once every 2 years, the in-service
training of certified school personnel and administrators include training
on current best practices regarding the identification and treatment of
attention deficit disorder and attention deficit hyperactivity disorder, the
application of non-aversive behavioral interventions in the school
environment, and the use of psychotropic or psychostimulant medication for
school-age children.
(c) This Section does not prohibit school medical staff, an
individualized educational program team, or a professional worker (as defined
in Section 14-1.10 of this Code)
from recommending that a
student be evaluated by an appropriate medical practitioner or prohibit
school personnel from consulting with the practitioner with the consent
of the student's parents or guardian.
(Source: P.A. 95-331, eff. 8-21-07.)
|